(Q34758085)

4 August 2017

1 reference

title

Immune escape as a fundamental trait of cancer: focus on IDO. (English)

1 reference

evasion of host immune response

4 August 2017

1 reference

G C Prendergast

1

1 reference

PubMed ID

18317452

4 August 2017

language of work or name

English

0 references

publication date

3 March 2008

1 reference

4 August 2017

1 reference

4 August 2017

27

1 reference

4 August 2017

3889-3900

1 reference

4 August 2017

28

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2008.35

4 August 2017

0 references

cites work

Bin1 interacts with and restrains the DNA end-binding protein complex Ku.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Bin1 homolog hob1 supports a Rad6-Set1 pathway of transcriptional repression in fission yeast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Cytoplasmic transport of Stat3 by receptor-mediated endocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Regulation of immune responses by L-arginine metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Solid cancers after bone marrow transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

The immunobiology of cancer immunosurveillance and immunoediting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Modulation of tryptophan catabolism by regulatory T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

T cell apoptosis by tryptophan catabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

31 March 2020

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

TGF-beta and CD4+CD25+ regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Germ line polymorphism in metastatic progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Myc influences global chromatin structure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Adaptive immunity maintains occult cancer in an equilibrium state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Distinct role of macrophages in different tumor microenvironments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Mast cells are essential intermediaries in regulatory T-cell tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

IDO expression by dendritic cells: tolerance and tryptophan catabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Creating immune privilege: active local suppression that benefits friends, but protects foes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Targeted deletion of the suppressor gene bin1/amphiphysin2 accentuates the neoplastic character of transformed mouse fibroblasts.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Indoleamine 2,3-dioxygenase in immune suppression and cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Prevention of allogeneic fetal rejection by tryptophan catabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Decreased c-kit function inhibits enhanced skin carcinogenesis in c-Ha-ras protooncogene transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Calreticulin exposure dictates the immunogenicity of cancer cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

31 March 2020

Arginine and immunity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Cancer immunologists and cancer biologists: why we didn't talk then but need to now

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

The BAR domain proteins: molding membranes in fission, fusion, and phagy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Tryptophan metabolism in carcinoma of the breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

hob1+, the fission yeast homolog of Bin1, is dispensable for endocytosis or actin organization, but required for the response to starvation or genotoxic stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

BIN1 is a novel MYC-interacting protein with features of a tumour suppressor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

c-MYC impairs immunogenicity of human B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

CT screening for lung cancer: five-year prospective experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Immunosuppressive networks in the tumour environment and their therapeutic relevance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.35

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2008.35

1 reference

PubMed ID

18317452

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

18317452